Objectiu de la convocatòria

IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe's growing health challenges, and secure the future international competitiveness of Europe's pharmaceutical industry.

Característiques principals

The Call has the following topics:

-          Topic 1: Development of Quantitative System Toxicology (QST) approaches to improve the understanding of the safety of new medicines

-          Topic 2: Establishing impact of respiratory syncytial virus (RSV) infection, resultant disease and public health approach to reducing the consequences

Topics under the Big Data for Better Outcomes programme:

-          Topic 3: Real World Outcomes Across the AD (Alzheimer's disease) Spectrum (ROADS) to Better Care

-          Topic 4: Development of an outcomes-focused platform to empower policy makers and clinicians to optimise care for patients with haematologic malignancies

Característiques principals

This Call is being run in a two stage submission and evaluation process.

Key dates

Stage 1 submission start date: 6 October 2015

Stage 1 submission deadline: 12 January 2016 – 17:00:00 Brussels time

Short proposals for this call can only be done through the IMI SOFIA software tool: https://sofia.imi.europa.eu/Pages/Login.aspx?ReturnUrl=%2fPages%2fDefault.aspx

Convocatòria (URL)

http://www.imi.europa.eu/content/imi-2-call-6-0

Dotació

IMI JU collaborative projects are implemented through a co-financing scheme. The IMI JU grants financial support to the eligible entities, while the other entities (including the EFPIA companies) participate in the project with their own resources.

The EU contribution is:

Topic 1: 8.000.000 EUR

Topic 2: 14.500.000 EUR

Topic 3: 4.000.000 EUR

Topic 4: 20.000.000 EUR

http://www.imi.europa.eu/content/stage-1-17